DAMOCLES Diagnostics
Created in 2023
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
157Activities
Technologies
Entity types
Location
87000 Limoges, France
Limoges
France
Employees
Scale: 2-10
Estimated: 5
SIREN
983306960Engaged corporates
5
5 0Added in Motherbase
1 year, 3 months ago
healthtech Value proposition
Biophysical monitoring for One Health
DAMOCLES Diagnostics is a deeptech start-up founded in 2023 in Limoges. It develops an innovative technology that allows the measurement of the biophysical properties of a microorganism in a few minutes, without labeling and respecting the living. The first targeted application is the antibiotic sensitivity test (AST) which is very fast and automated.
The innovation is based on the transformation of a proven technology in oncology, adapted to medical microbiology laboratories, both in human and animal health. The DAMAST system includes a machine, a diagnostic software and kits for a wide range of applications in microbiology.
DAMOCLES Diagnostics has validated its DAMAST system on more than 500 bacteria/antibiotic combinations, with performances in accordance with CE-IVD regulations. A second internal clinical study is underway on another panel of bacterial species and antibiotics.
Our team is composed of 8 people with transdisciplinary skills. We are supported by the INSERM U1092 RESINFIT and U1308 CAPTUR laboratories, which gives us privileged access to cutting-edge technical platforms.
Having received many expressions of interest from future customers (private laboratories and hospitals), we aim for the industrialization of the DAMAST system in 2025, followed by the launch of a clinical trial in 2026.
Antibiotics, AST, CE IVD, IVD, AMR, One Health, MedTech, and DeeptechOriginal language
Révolutionnons l'antibiogramme en 2 heures : des résultats rapides, des vies préservées, une antibiorésistance combattue
DAMOCLES Diagnostics est une start-up deeptech fondée en 2023 à Limoges. Elle développe une plateforme innovante, DAMAST, qui permet de réaliser des antibiogrammes rapides en seulement 2 heures, contre 12 à 24 heures pour les méthodes conventionnelles actuelles. Le système comprend, en plus de l’automate DAMAST, un logiciel de diagnostic et d’analyse automatisée des données, ainsi que des kits permettant une large gamme d'applications en microbiologie, à la fois en santé humaine (sepsis, infections urinaires) et animale.
Notre équipe est composée de 6 personnes aux compétences transdisciplinaires. Nous sommes soutenus par les laboratoires INSERM U1092 RESINFIT et U1308 CAPTUR, ce qui nous permet d'avoir un accès privilégié à des plateaux techniques de pointe.
Ayant reçu de nombreuses manifestations d'intérêt de la part de futurs clients (laboratoires privés et hôpitaux), nous visons l'industrialisation du système DAMAST en médecine vétérinaire 2025, puis le lancement d'un essai clinique en santé humaine en 2026.
DAMOCLES Diagnostics | RÉVOLUTIONNE LA PRISE EN CHARGE DES INFECTIONS BACTÉRIENNES
https://www.damoclesdx.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 ESTER Technopole Think Tanks | ESTER Technopole Think Tanks | Other 7 Nov 2024 | | |
 France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | France Biotech Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 1 Oct 2024 | | |
 Agence pour la Valorisation de la Recherche Universitaire du Limousin (AVRUL) Research, Research Services | Agence pour la Valorisation de la Recherche Universitaire du Limousin (AVRUL) Research, Research Services | Other 7 Nov 2024 | | |
 AQUITI Gestion Startup accelerator & VC, Venture Capital and Private Equity Principals | AQUITI Gestion Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 23 Jul 2023 | | |
 French Tech Limousin French Tech, IT Services and IT Consulting | French Tech Limousin French Tech, IT Services and IT Consulting | Other 21 Sep 2024 | | |